Quantitative Computed Tomography Analysis Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma von Lee, Y, Cristini, V, Varadhachary, G.R, Katz, M, Wang, H, Bhosale, P, Tamm, E.P, Fleming, J.B, Koay, E.J

Volltext

A Computed Tomography Imaging Feature of Pancreatic Cancer As a Predictive Biomarker for Escalated Dose Radiation Therapy von Moningi, S, Amer, A, Colbert, L.E, Lee, Y, Hall, W.A, Erickson, B.A, Varadhachary, G.R, Das, P, Taniguchi, C.M, Fleming, J.B, Katz, M, Crane, C.H, Koay, E.J

Volltext

Dose Escalation With an Intensity Modulated Radiation Therapy Technique in 15 to 28 Fractions Is Better Tolerated Than Are Standard Doses of 3DCRT for LAPC von Colbert, L.E, Moningi, S, Chadha, A.S, Wolff, R.A, Varadhachary, G.R, Fleming, J.B, Katz, M, Taniguchi, C.M, Das, P, Krishnan, S, Koay, E.J, Crane, C.H

Volltext

Response to and Survival after First-Line FOLFIRINOX or Gemcitabine/Nab-Paclitaxel for Localized Pancreatic Ductal Adenocarcinoma von Perri, G., Prakash, L., Varadhachary, G.R., Koay, E.J., Kim, M., Ikoma, N., Tzeng, C., Lee, J.E., Katz, M.H.

Volltext

OncoPaC-1: An Open-label, Single-Arm Pilot Study of Phosphorus-32 Microparticles Brachytherapy in Combination with Gemcitabine +/- Nab-Paclitaxel in Unresectable Locally Advanced P... von Bhutani, M.S., Klapman, J.B., Tuli, R., El-Haddad, G.E., Hoffe, S., Wong, F.C.L., Fogelman, D.R., Lo, S., Nissen, N.N., Hendifar, A.E., Varadhachary, G.R., Katz, M.H., Erwin, W.D., Tamm, E.P., Singh, B.A.S., Mehta, R., Soman, A., Kraszewski, A., Cazacu, I.M., Herman, J.M.

Volltext

Liquid Biopsies as a Predictor of Response in Pancreatic Adenocarcinoma Following Neoadjuvant Chemoradiation von Bernard, V., Kim, D.U., Castillo, J., San Lucas, F.A., Stephens, B., Mulu, F., Herman, J.M., Taniguchi, C.M., Koay, E.J., Varadhachary, G.R., Katz, M.H., Alvarez, H.A., Maitra, A.

Volltext

Pembrolizumab in advanced rare cancers von Naing, A., Meric-Bernstam, F., Karp, D., Rodon, J.A., Piha-Paul, S.A., Subbiah, V., Hong, D.S., Pant, S., Fu, S., Janku, F., Yap, T.A., Tsimberidou, A.M., Dumbrava, E E Ileana, Colen, R.R., Hess, K.R., Campbell, M.T., Tu, S.-M., Jimenez, C., Habra, M.A., Varadhachary, G.R.

Volltext

1270P - Pembrolizumab in advanced rare cancers von Naing, A., Meric-Bernstam, F., Karp, D., Rodon, J.A., Piha-Paul, S.A., Subbiah, V., Hong, D.S., Pant, S., Fu, S., Janku, F., Yap, T.A., Tsimberidou, A.M., Dumbrava, E E Ileana, Colen, R.R., Hess, K.R., Campbell, M.T., Tu, S.-M., Jimenez, C., Habra, M.A., Varadhachary, G.R.

Volltext

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset von Varadhachary, G. R., Karanth, S., Qiao, W., Carlson, H. R., Raber, M. N., Hainsworth, J. D., Greco, F. A.

Volltext

The prognostic significance of infiltrating lymphocytes in resectable pancreatic ductal adenocarcinoma in untreated versus neoadjuvant treated patients von Goldstein, J.B., Chatterjee, D., Zaid, M., Chaudhury, B., Elganainy, D., Halperin, D.M., Nejati, R., Wang, H., Katz, M.H., Lee, J.E., Fleming, J., Rodriguez Canales, J., Blando, J., Wistuba, I.I., Maitra, A., Wolff, R.A., Wang, H., Varadhachary, G.R., Koay, E.

Volltext